SURGE Therapeutics

SURGE Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing intraoperative cancer immunotherapy. Founded on research from Dr. Michael Goldberg's laboratory at Harvard Medical School, the company's SURGERx platform is an injectable, biodegradable hydrogel placed directly at the site of surgical tumor resection to provide extended, localized release of immunotherapy — addressing the surgery-induced inflammation that suppresses the immune system and allows residual disease to reawaken. Its lead program, SRG-514, completed Phase 1 dose escalation in breast cancer patients undergoing surgery and is being prepared for a registrational trial, with an additional IND cleared for a Phase 1/2a study in bladder cancer. SURGE has raised a $26M Series A and a $32M Series B. It is a therapeutics developer, not a software company, and publishes no developer program, API, or machine-readable interface.

SURGE Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Immunotherapy.

SURGE Therapeutics’ developer surface includes product news and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

5.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyPharmaceuticalsOncologyImmunotherapyDrug DeliveryClinical StageHealthLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 5.4/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/surge-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 4

The organization behind the API

Website

Website

About

About

News

News

LinkedIn

Other 2

Properties that don't map to a standard resource type

Team

Team

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: surge-therapeutics
name: SURGE Therapeutics
description: SURGE Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing intraoperative
  cancer immunotherapy. Founded on research from Dr. Michael Goldberg's laboratory at Harvard Medical School, the company's
  SURGERx platform is an injectable, biodegradable hydrogel placed directly at the site of surgical tumor resection to provide
  extended, localized release of immunotherapy — addressing the surgery-induced inflammation that suppresses the immune system
  and allows residual disease to reawaken. Its lead program, SRG-514, completed Phase 1 dose escalation in breast cancer patients
  undergoing surgery and is being prepared for a registrational trial, with an additional IND cleared for a Phase 1/2a study
  in bladder cancer. SURGE has raised a $26M Series A and a $32M Series B. It is a therapeutics developer, not a software
  company, and publishes no developer program, API, or machine-readable interface.
image: https://surgetx.com/wp-content/uploads/2021/06/SURGE_No-Slogan-COLOUR-1024x279.png
url: https://raw.githubusercontent.com/api-evangelist/surge-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Immunotherapy
- Drug Delivery
- Clinical Stage
- Health
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/surge-therapeutics-domain-security.yml
- type: Website
  url: https://surgetx.com/
- type: About
  url: https://surgetx.com/science/
- type: Team
  url: https://surgetx.com/team/
- type: News
  url: https://surgetx.com/news/
- type: Contact
  url: https://surgetx.com/contacts/
- type: LinkedIn
  url: https://www.linkedin.com/company/surge-therapeutics
- type: SecondaryMarket
  url: https://forgeglobal.com/surge-therapeutics_stock/
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: SURGE Therapeutics is a clinical-stage oncology drug developer whose entire web presence is a five-page WordPress
    marketing site (home, science, news, team, contacts); the only machine-readable endpoint on surgetx.com is WordPress core's
    default /wp-json CMS route index, and api./developer./docs./portal.surgetx.com are all NXDOMAIN.
  evidence:
  - url: https://surgetx.com/openapi.json
    status: 404
  - url: https://surgetx.com/.well-known/agent-card.json
    status: 404
  - url: https://surgetx.com/.well-known/security.txt
    status: 404
  - url: https://surgetx.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/surgetx
    status: 404
  - url: https://surgetx.com/wp-json
    status: 200
  checked: '2026-08-05'